Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

Download full-text PDF	Source
http://dx.doi.org/10.1093/jac/dkx382	DOI Listing

Publication Analysis

pharmacokinetics safety

safety phase

phase randomized

randomized open-label

open-label study

study intravenous

intravenous posaconazole

posaconazole patients

patients risk

risk invasive

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!